Consult-to-treatment conversion is the share of med spa consultations that end in a booked and paid treatment, measured over a window long enough for the patient to decide. Most practices cannot state theirs, because the denominator is never defined, and the ones that can usually find the loss sits after the appointment ends.
Filling the chair is a marketing problem with a marketing solution. Converting it is mostly an operations problem, and the parts that go wrong repeatedly are governed by rules that have nothing to do with sales technique. Three documents decide more of this number than any script does.
Define the denominator before you chase the rate
A consult conversion rate is only comparable to itself, and only when the denominator is written down. Decide three things first: what counts as a consult, how long a patient has to decide before that consult is counted as lost, and whether the rate is measured per provider or across the practice.
Those choices move the number more than anything said in the room: counting in-person consults with a thirty day window reports a far healthier rate than counting phone inquiries and closing at seven days. One rule keeps it honest. A patient told they were not a candidate is a clinical outcome, not a lost sale, and belongs outside the denominator.
The consult is a clinical appointment before it is a sales one
In North Carolina the first laser treatment is not supposed to be the same event as the conversation that sold it. The NC Medical Board's position statement on laser surgery, adopted July 1999 and amended May 2021 and current as of September 2026, puts a clinical examination in front of that first treatment.
The statement is specific about who performs it: "good medical practice requires that each patient be examined by a physician, physician assistant, or nurse practitioner licensed or approved by this Board prior to receiving the first laser hair and tattoo removal treatment". It adds that the supervising physician should be on site or readily available.
Read as a conversion constraint rather than a compliance footnote, that is a scheduling fact. A consult ending in enthusiasm and no dated appointment has not converted, it has deferred. Booking the examination and the first session while the patient is still in the room keeps the enthusiasm a follow-up call loses.
Two limits matter. The laser statement addresses lasers and tattoo removal, not injectables, fillers or chemical peels, and position statements are not statutes. Separately, the Board's position on the corporate practice of medicine, amended September 2025, holds that a business practising medicine in North Carolina must be owned in its entirety by the Board's licensees or the statutory combinations. The clinical recommendation is not the front desk's to make.
HIPAA's face-to-face carve-out is why the room beats the follow-up
HIPAA treats a recommendation made in the room differently from the same recommendation sent afterwards. Under 45 CFR 164.508, a covered entity "must obtain an authorization for any use or disclosure of protected health information for marketing", with one carve-out that matters here: a face-to-face communication made by the covered entity to the individual.
That carve-out is the strongest structural argument for finishing the recommendation before the patient stands up. A second treatment area, a package or a maintenance interval suggested in person sits inside it. Emailed a week later, keyed to what the patient was treated for, it is a different act under the same rule.
Two further lines change how a consult runs. An authorization must name the information, the purpose, an expiration and a right to revoke, and carry the patient's signature and date, so an intake-form checkbox is not one. And treatment may not be conditioned on signing it. Whether a practice is a covered entity is decided by 45 CFR 160.103.
What may be claimed about results, in the room and after
The FTC's Health Products Compliance Guidance applies to what is said in a consult, not only to what is printed in an ad. Its two principles are that advertising must be truthful and not misleading, and that adequate substantiation must exist before an objective claim goes out. Health-related claims generally need competent and reliable scientific evidence.
Two specifics land in the room. Testimonials do not constitute substantiation, and disclaiming dramatic results with statements like results not typical does not cure the deception, so a binder of the practice's best photographs is a claims hazard as well as a sales tool. Show a range rather than a ceiling, and state the session count before the price. The guidance names no aesthetic procedures and has no force of law.
The follow-up needs a consent the room did not
Most consult conversion is lost in the days after the appointment, which is where the rules tighten rather than relax. The FCC's rules implementing the Telephone Consumer Protection Act, 47 CFR 64.1200, require prior express written consent for a call or text that constitutes telemarketing and is sent with an autodialer or an artificial or prerecorded voice.
The rule defines that consent narrowly: a written agreement bearing the signature of the person called, clearly authorising advertising or telemarketing messages by those means, and naming the number they may be sent to. A number given at intake for clinical contact is not, on its own, that agreement.
Revocation is equally specific. A patient may revoke by any reasonable method, and stop, quit, end, revoke, opt out, cancel or unsubscribe sent in reply to a text counts as reasonable per se, honoured within ten business days. Solicitations to residential subscribers are restricted before 8 a.m. and after 9 p.m. local time. So the consent belongs on the form signed at the consult, and the stop word must reach the system that sends.
Where a consult stalls, and what governs the fix
Each row is a different stall with a different owner. Only one of them is a sales problem, which is the point: answering a scheduling constraint with better objection handling is a misdiagnosis.
| Where it stalls | What governs it | What the practice does |
|---|---|---|
| Before a first laser session | NC Medical Board 5.1.2: an examination by a physician, PA or NP before a first laser or tattoo removal treatment | Set the examination and the first session as dated appointments in the room, with the supervising clinician on site or readily available |
| At the price | Nothing legal. This row is operational, and the one genuine sales problem on the list | A dated next step taken before the patient stands up, and a written plan they leave holding |
| In the recommendation | 45 CFR 164.508: marketing use of protected health information needs a signed authorization, with a face-to-face carve-out | Finish the recommendation in person, and treat anything sent afterwards as a separate consent question |
| In the claim | FTC guidance: objective claims need substantiation, and testimonials are not substantiation | Describe what the labelling and the treating clinician support, and state the session count before the price |
| In the follow-up | 47 CFR 64.1200: prior express written consent, signed and naming the number, revocation honoured within ten business days | Capture consent at the consult on the signed form, and wire the stop word into the system that sends |
Lead follow-up and automation: what this looks like when it runs
Lead follow-up and automation is the criterion this post lands on, and in practice it means a sequence that starts from a recorded consent and a dated decision rather than from a spreadsheet someone remembers on Friday. Automated booking sits beside it, holding the examination and the first session as two appointments set while the patient is still in the room.
Those systems run in production for Charlotte businesses today: live-availability booking that calculates real openings and confirms automatically, instant replies to inquiries arriving at any hour, and reminder and rebooking sequences. The consult-specific work is wiring the consent record and the decision date into the same place, so a sequence can tell an undecided patient from a declined one.
The privacy controls around it are plumbing decisions made before a campaign runs: patient information stays out of ad platforms and pixels, forms land in a system the practice owns, and a business associate agreement is signed where an engagement genuinely touches protected health information. The practice stays the covered entity.
Sources
- NC Medical Board Position Statement 5.1.2: Laser Surgery - Adopted July 1999, amended May 2021. The Board's position that good medical practice requires each patient to be examined by a physician, physician assistant or nurse practitioner licensed or approved by the Board prior to a first laser hair or tattoo removal treatment, and that the supervising physician should be on site or readily available. The statement covers lasers and does not address injectables, fillers or chemical peels. Position statements are not statutes.
- NC Medical Board Position Statement 10.1.2: Corporate Practice of Medicine - Adopted March 2016, amended September 2025. The Board's position that businesses practising medicine in North Carolina must be owned in their entirety by holders of active NC licenses or one of the combinations permitted in N.C. Gen. Stat. 55B-14, with hospital, HMO, public-clinic and charitable exceptions. The statement never uses the words med spa, does not define which aesthetic services are the practice of medicine, and is a position statement rather than a statute.
- 45 CFR 164.508, HIPAA Privacy Rule: uses and disclosures for which an authorization is required - That a covered entity must obtain an authorization for any use or disclosure of protected health information for marketing, except a face-to-face communication made by the covered entity to the individual or a promotional gift of nominal value; the core elements of a valid authorization and the right to revoke; and the prohibition on conditioning treatment on signing one. Read from the Cornell LII mirror because ecfr.gov and hhs.gov may refuse automated fetches; the official text is at ecfr.gov, title 45, section 164.508. Whether a given practice is a covered entity is decided by 45 CFR 160.103, not by this section.
- 47 CFR 64.1200, FCC delivery restrictions implementing the Telephone Consumer Protection Act - Prior express written consent for autodialed or artificial-voice telemarketing, and the rule's definition of it as a signed agreement naming the number; revocation by any reasonable means, with stop, quit, end, revoke, opt out, cancel or unsubscribe reasonable per se and honoured within ten business days; the 8 a.m. to 9 p.m. restriction on telephone solicitations to residential subscribers. Read from the Cornell LII mirror; official text at ecfr.gov, title 47, section 64.1200. Whether a given platform is an automatic telephone dialing system is a legal question this text does not settle.
- Health Products Compliance Guidance (Federal Trade Commission) - Issued December 2022. The FTC's two principles, that advertising must be truthful and not misleading and that advertisers must have adequate substantiation for objective claims before dissemination; that health-related claims generally require competent and reliable scientific evidence; that testimonials do not constitute substantiation and that a results-not-typical disclaimer does not cure a deceptive dramatic-result testimonial. The guidance is written around foods, supplements, drugs and devices, does not name med spas or aesthetic procedures, is business guidance without the force of law, and states no penalties.